| Literature DB >> 18304570 |
Denise Sickert1, Kerstin Kroeger, Christophe Zickler, Edwige Chokote, Barbara Winkler, Jean-Michel Grenet, Francois Legay, Annette Zaar.
Abstract
Detection of anti-drug antibodies (ADA) can be difficult, if not impossible, in the presence of drug in the sample. This is a particular concern with therapeutic monoclonal antibodies (mAbs), which have typically longer half-lives than other proteins. For detection of ADA in presence of high drug concentrations, assay choice is limited to ELISA-like methods, capable of incorporating acid dissociation procedures to separate drug-ADA immune complexes. To our knowledge, Biacore assays have not been shown to be directly compatible with acid dissociation procedures, until now. As a consequence, steps to ensure adequate clearance of the drug are prerequisite to enable sensitive detection of ADA. Here we describe the development of a novel, rapid and highly drug tolerant Biacore method that uses an acid dissociation step to detect ADA in the presence of excess drug in human serum. Removal of drug after acid treatment is not required.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18304570 DOI: 10.1016/j.jim.2008.01.010
Source DB: PubMed Journal: J Immunol Methods ISSN: 0022-1759 Impact factor: 2.303